Differences in age and sex distribution as well as FAB (French-American-British classification) types have been reported for acute leukemias in several countries. We studied the demographics and response to treatment of patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL) between 1989 and 2000 in Teresina, Piauí, and compared these results with reports from Brazil and other countries. Complete data concerning 345 patients (230 ALL, 115 AML) were reviewed. AML occurred predominantly in adults (77%), with a median age of 34 years, similar to that found in the southeast of Brazil but lower than the median age in the United States and Europe (52 years). FAB distribution was similar in children and adults and FAB-M2 ...
Since 2001, the World Health Organization (WHO) classification for hematopoietic and lymphoid neopla...
CONTEXT: Young patients affected by acute myeloid leukemia (AML) achieve complete remission (CR) usi...
Acute leukemia (AL) is a rare, potentially curable, aggressive neoplasm of hematopoietic origin. AL ...
Differences in age and sex distribution as well as FAB (French-American-British classification) type...
Differences in age and sex distribution as well as FAB (French-American-British classification) type...
CONTEXT AND OBJECTIVE: Geographical variations have been described in acute myelogenous leukemia (AM...
CONTEXT AND OBJECTIVE: Geographical variations have been described in acute myelogenous leukemia (AM...
CONTEXT AND OBJECTIVES: The incidence of acute leukemia (AL) subtypes varies according to geographic...
Objective: To identify how the Brazilian hematology centerstreated and diagnosed cases of acute myel...
A leucemia mielóide aguda (LMA) com diferenciação e t(8;21) ou LMA M2 com t(8;21), pela classificaçã...
Introduction: Acute myeloid leukemia (AML) has variable incidence in different regions of Brazil. Ob...
IntroductionLeukemia is the most common cancer in children and has the highest rates of incidence in...
A leucemia mielóide aguda (LMA) acomete pacientes de todas as faixas etárias com freqüência aumentad...
We describe 195 cases of adult T-cell leukemia/lymphoma (ATLL) reported to the national registry of ...
tion classification for hematopoietic and lymphoid neoplasms has provided a framework for defining a...
Since 2001, the World Health Organization (WHO) classification for hematopoietic and lymphoid neopla...
CONTEXT: Young patients affected by acute myeloid leukemia (AML) achieve complete remission (CR) usi...
Acute leukemia (AL) is a rare, potentially curable, aggressive neoplasm of hematopoietic origin. AL ...
Differences in age and sex distribution as well as FAB (French-American-British classification) type...
Differences in age and sex distribution as well as FAB (French-American-British classification) type...
CONTEXT AND OBJECTIVE: Geographical variations have been described in acute myelogenous leukemia (AM...
CONTEXT AND OBJECTIVE: Geographical variations have been described in acute myelogenous leukemia (AM...
CONTEXT AND OBJECTIVES: The incidence of acute leukemia (AL) subtypes varies according to geographic...
Objective: To identify how the Brazilian hematology centerstreated and diagnosed cases of acute myel...
A leucemia mielóide aguda (LMA) com diferenciação e t(8;21) ou LMA M2 com t(8;21), pela classificaçã...
Introduction: Acute myeloid leukemia (AML) has variable incidence in different regions of Brazil. Ob...
IntroductionLeukemia is the most common cancer in children and has the highest rates of incidence in...
A leucemia mielóide aguda (LMA) acomete pacientes de todas as faixas etárias com freqüência aumentad...
We describe 195 cases of adult T-cell leukemia/lymphoma (ATLL) reported to the national registry of ...
tion classification for hematopoietic and lymphoid neoplasms has provided a framework for defining a...
Since 2001, the World Health Organization (WHO) classification for hematopoietic and lymphoid neopla...
CONTEXT: Young patients affected by acute myeloid leukemia (AML) achieve complete remission (CR) usi...
Acute leukemia (AL) is a rare, potentially curable, aggressive neoplasm of hematopoietic origin. AL ...